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Canine Insulinoma: A Case Report 
and Review of the Current Literature 
LYNN McDERMOTI, DVMt, SCOT SWAINSON, DVMtt, AND MONICA HOWARD, DVM, PHDttt 
Insulinoma is a rare disease of dogs, yet it 
is recognized as the most common islet cell 
tumor of the endocrine pancreas.I Dogs with 
insulinomas often have similar clinical signs 
and clinical pathology data, making a pre-
sumptive diagnosis easier for a veterinar-
ian. Arriving at a definitive diagnosis, how-
eve~ requires both surgery and 
histopathology. 2 Veterinarians, therefore, 
must be aware of the biologic behavior of 
the tumor, the typical clinical signs and clini-
cal pathology data, treatment options and 
prognostic factors in order to warrant the 
search for a definitive diagnosis. 
An insulinoma is a functional adenocar-
cinoma of the beta cells of the endocrine pan-
creas.3 Although most of the clinical signs 
are due to hyperinsulinism, insulinomas 
also produce serotonin, gastrin, somatosta-
tin, and corticotropin.4 Hyperinsulinism in-
terrupts glucose homeostasis, causing neu-
rologic signs associated with hypoglycemia. 
Neuroglucopenic signs include seizures, 
ataxia, weakness, muscle atrophy, apparent 
blindness, appendicular hyporeflexia, be-
havior changes and even coma. 
Although they have occurred in young 
dogs, insulinoma occurs most frequently in 
middle aged to old dogs with an average age 
of nine years .8 The breeds most commonly 
affected are German Shepherds, Irish Set-
ters, Boxers, Golden Retrievers, and the Ter-
rier breeds.B,9 The prevalence of insulin om as 
in large breeds was also confirmed in one 
study where greater than 72 percent of the 
dogs weighed greater than 25 kilograms.9 
There is no sex predilection.I ,8,9 Unlike hu-
man insulinomas, which are often benign, 
greater than 75 percent of functional tumors 
in dogs are malignant.B These adenocarci-
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nomas most commonly metastasize to re-
gionallymph nodes and the liver in approxi-
mately 50 percent of the cases.IO 
The following case report illustrates the 
diagnostic approach for canine insulinoma. 
Furthermore, it explains one treatment op-
tion and the complications with the proce-
dure. The discussion following compares and 
contrasts other findings with those of this 
case. 
Case Report 
A twelve year old spayed female mixed breed 
dog was referred to Iowa State University 
Veterinary Teaching Hospital for clinical 
evaluation of lethargy, behavior changes, 
muscle tremors, incontinence, polyuria, and 
polydipsia. These clinical signs had been oc-
curring over the last month and a half. The 
referring veterinarian had been treating the 
dog with 0.01 mg/kg of thyroxine twice a day 
for hypothyroidism. Estrogen tablets were 
given twice a week for treatment of urinary 
incontinence. Blood chemistry revealed hy-
poglycemia [50 mg/dL; ref: 65-115mg/dL] 
and the referring veterinarian advised the 
owner to feed the dog four times a day. The 
owner was feeding a variety of commercial 
dog food. 
On presentation to ISU Veterinary 
Teaching Hospital, the dog had a tempera-
ture of101.50 F, a pulse rate of140 beats per 
minute, and a panting respiratory rate. Her 
mucous membranes were pink, capillary re-
fill time was less than 2 seconds, and hy-
dration was normal. The dog weighed 7 ki-
lograms at presentation. 
A CBC was performed after physical ex-
amination. The only clinical abnormality 
was a slight lymphopenia. Blood chemistries 
were also performed and hypercalcemia 
[11.7 mg/dL; ref: 9.3-1 1.5 mg/dL], renal 
azotemia [BUN= 61 mg/dL; ref: 10-25 mgt 
dL] [Creatinine=2.0 mg/dL; ref: 0.5-1.5 mg/ 
dL], hypoglycemia [50 mg/dL; ref: 65-115 
mg/dL], and hyperproteinemia [7.2 g/dL; ref: 
5.1-7.0 g/dL] were found. A urinalysis re-
vealed a low specific gravity of 1.014. The 
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TABLE 1: Day 1 Laboratory Results 
Insulin = 26.7 I1U/mL (Normal = 1-20 I1U/mL) 
Glucose = 50 mg/dL (Normal = 65-115 mg/dL) 
IGR= 53.4 (Normal < 13.5) 
AIGR= 133.5 (Norma! < 30) 
IGR = [insulin! "Ulml x 100 
[glucose] mg/dL 
AIGR = [insulin] blU/m1 x 100 
[glucose] mg/dL - 30 
thesia was induced with thiopental at 8 mg/ 
kg and lidocaine at 8 mg/kg intravenously. 
A pediatric circle using isoflurane and oxy-
gen was used to maintain anesthesia. Lac-
tated ringers solution with 5% dextrose was 
given intravenously at a rate of5 ml/kg/hour 
throughout the surgery. Perioperative 
Cefazolin at 22 mg/kg was also given intra-
venously. During the surgery, intermittent 
positive pressure ventilation (lPPV) was em-
ployed at a breathing rate of15 breaths per 
minute at a tidal volume ofl05 ml. Glucose 
measurements were taken at the start and 
insulin level on this same day was found to one hour into the surgery and were 263 mg/ 
be high [26.7 /lUlml; ref: 1-20 /lU/mL]. The dL and 155 mg/dL, respectively. Blood gas 
insulin to glucose ratio and amended insu- analysis was performed approximately 
lin to glucose ratio were abnormally elevated ninety minutes into the surgery. The results 
as well (Table 1). are listed in Table 2. Thirty minutes before 
Abdominal radiographs were taken. surgery was complete , 0 .01 mg/kg of 
Borderline bilateral decreased kidney size buprenorphine was given intravenously. 
was identified. Ultrasound was performed A standard approach for an exploratory 
to evaluate the cranial abdomen and the celiotomy was performed. Examination of 
pancreas in particular. Using a 7.5 MHz the right lobe of the pancreas revealed an 
transducer, 2D real-time ultrasonic evalua- adhesion between the cecum and the right 
tion of the abdomen revealed an 8 mm x 13 lobe of the pancreas. The cecal adhesions 
mm hyperechoic elliptical lesion in the area were broken down with blunt dissection and 
of the right lobe of the pancreas. No other about one-third of the distal right pancre-
masses were evident in the abdomen. atic lobe was resected using 3-0 nylon liga-
The patient returned approximately one tures [Ethicon]. Further examination of the 
week later for further evaluation and an abdomen revealed a discolored 
exploratory celiotomy. Preoperatively the gastropancreatic lymph node. The entire 
dog had a packed cell volume of 41.4 % and node was removed. All tissues were submit-
a total protein of6.9 g!dL. The CBC was nor- ted for histopathologic evaluation. Prior to 
mal except for a slight lymphopenia. Blood closure the pancreas was gently palpated for 
chemistries revealed azotemia [BUN 52 mg! any irregularities. A small pea-sized nodule 
dL; ref: 10-25 mg/dL] [Creatinine= 2.0 mg/ was discovered in the mid-portion ofthe left 
dL; ref: 0.5-1.5] and hypoglycemia [56 mg/ pancreatic lobe. This nodule was removed 
dL; ref: 65-115]. .-----__________________ ---, 
Thoracic radiographs were 
taken and evaluated for evidence 
of pulmonary metastasic disease. 
No radiographic evidence of meta-
static disease was identified. 
TABLE 2: Intraoperative Blood Gas Results 
The dog was placed in the in-
tensive care unit the day before 
surgery. Lactated ringers solution 
with 5% dextrose and 20 mEq of 
potassium chloride per liter was 
given intravenously at a rate of20 
mllhour. 
Pre-anesthesia medications of 
Arterial 
pH 
pC02 (mmHg) 
p02 (mmHg) 
HC03 (mmollL) 
TC02 (mmollL) 
SBE (mmollL) 
SAT% 
0 2 CTVol% 
Hb (g!dL) 
Run time 
0.1 mg/kg of oxymorphone and Comments 
0.005 mg/kg of glycopyrrolate 
Sample 1 
7.302 
47.3 
521 
23.5 
25 
-3.1 
100 
21.4 
Sample 2 
7.202 
47.0 
462.9 
17.8 
19.3 
-8.9 
99.8 
13.1 
8.4 
11 :36 
IPPV:ISO+ 
100% 0 2 
were given intravenously. Anes- L _____________________ ....l 
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by placing ligatures approximately 2 cm 
from both sides of the nodule and 
transecting the pancreas at these two points. 
This nodular growth was also submitted for 
histopathology. A small punch biopsy of the 
liver was taken for histopathologic 
examinatior although the liver appeared 
normal grossly. Approximately 30%-40% of 
the pancreas was removed in the partial 
pancreatectomy of the left and right lobes. 
No other gross abnormalities were identi-
fied on abdominal exploration. 
Postoperatively, the dog was placed in 
the intensive care unit. The patient was 
placed on lactated ringers solution plus 20 
mEq of potassium chloride per liter at a rate 
of 36 ml/hour. Buprenorphine at 0.01 mg/ 
kg was given intravenously every six hours 
for two doses. Oral feedings were withheld 
for 48 hours postoperatively and the dog was 
monitored for signs of pancreatitis [ego vom-
iting, abdominal pain, and increased body 
temperature]. Blood glucose levels were 
checked periodically, and a marked hyper-
glycemia became evident four days after the 
surgery. The dog was maintained on lactated 
ringers solution plus 20 mEq of potassium 
chloride per liter at a rate of 30 ml/hour on 
day 2 and 15 ml/hour on day 3. The dog re-
covered well from surgery as no fever, vom-
iting, diarrhea, seizures, or tremors were 
noted. The packed cell volume, pulse, and 
respiratory rate were also normal in the re-
covery period. Approximately 48 hours af-
ter surgery, the dog was hand fed frequent 
meals of bottled baby food. Approximately 
four days after the surgery the dog was fed 
Hill's I1d.© The patient was discharged five 
days after surgery. The owners were in-
structed to monitor the patient for signs of 
hyperglycemia [i.e. polyuria, polydipsia, and 
polyphagia]. 
Histopathology of the mesenteric lymph 
node revealed the replacement of approxi-
mately 95% of the normal nodal architec-
ture by nests of neoplastic epithelial cells 
arranged in packets along a fine fibrovas-
cular stroma. The cells were large with clear 
to eosinophilic cytoplasm and vesicular nu-
clei. Immunohistochemical stains of the 
node showed the neoplastic cells stained dif-
fusely for insulin. A diagnosis of metastatic 
insulinoma was made. 
The liver was within normal histologic 
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limits. The pancreas showed areas of hem-
orrhage and congestion with exocrine pan-
creatic hyperplasia. A mild periductallym-
phocytic infiltrate was also evidenced, but 
no neoplastic cells were witnessed. Addi-
tional sections of the pancreatic biopsy were 
made and evaluated. The subsequent at-
tempt isolated neoplastic cells similar to 
those found in the lymph node and the di-
agnosis of insulinoma was confirmed in the 
pancreas. 
Five days after discharging the dog and 
ten days after the surgery, the patient de-
veloped vomiting and became listless. The 
referring veterinarian performed blood 
chemistry analysis which showed azotemia 
[BUN= 68 mg/dL, Creatinine= 3.2mg/dL], 
profound hyperglycemia [686 mg/dL], in-
creased liver enzymes [Alkaline phos-
phatase= 452 IU], hyperphosphatemia 
[phosphorus = 10.5], hyponatremia [120 
mmollL], hypochloremia [96.4 mmollL], and 
hyperkalemia [5.8 mmollL]. 
A urinalysis revealed a specific gravity 
ofl.025 and a 2+ glucose. A CBC revealed a 
leukocytosis and granulocytosis as well as 
an anemia and thrombocytosis. The refer-
ring veterinarian treated the dog with 7.5 
units of NPH insulin subcutaneously. Vom-
iting was controlled by treating with 
metoclopramide at 2 mg/kg intravenously. 
The dog returned to ISU the following 
day after seeing the referring veterinarian. 
Hyperlipasemia [1090UIL; ref: 0-400 UIL] 
was found on blood work. A diagnosis of pan-
creatitis was made and the dog was admit-
ted for supportive therapy. Oral feedings 
were withheld for 72 hours and the patient 
was maintained on lactated ringers solution 
with 20 mEq ofKCI per liter and 2 mglkg of 
metoclopramide added. The fluids were 
given at a rate of 20 ml/hour. Three days 
later the patient was offered Hill's I1d© with-
out incident. The lipase was rechecked and 
was decreasing. The dog was discharged five 
days after admittance. 
Discussion 
Insulin is a hormone which is part of a com-
plex system which maintains glucose ho-
meostasis. Insulin acts to increase stored 
energy by promoting glyocogenesis and in-
hibiting glycogenolysis by liver and muscle.ll 
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In adipose tissue, insulin prevents the 
breakdown of fat and stimulates glycogen 
and fat synthesisP In addition to increas-
ing energy storage, insulin is responsible for 
stimulating glucose transport in certain or-
gans such as muscle and adipose tissueY 
The brain, however, is insulin-independent 
and relies on simple diffusion of glucose 
through the blood-brain barrier,12 Because 
glucose is the major fuel for the brain and 
carbohydrate reserves are limited, the brain 
is especially sensitive to hypoglycemia. l2 
The secretion of insulin from beta cells 
is influenced primarily by the blood glucose 
concentration in the normal dog. l2 As blood 
glucose rises insulin is secreted and as it 
falls secretion is inhibited. Insulinomas, 
however, are often partially or fully autono-
mous and the normal inhibition of insulin 
secretion with low blood glucose is inter-
rupted.4 The continued insulin secretion fur-
ther exacerbates the falling glucose levels 
by inhibiting gluconeogenesis and glyco-
genolysis.l2 As a result, the blood glucose 
level plummets until the body compensates. 
The hypothalamus responds to the hypogly-
cemia by sending stimuli to the sympathetic 
nervous system.l Epinephrine is released 
from the chromaffin cells of the adrenal 
medulla and acts directly on the liver to in-
crease glycogenolysis.l2 Epinephrine also in-
creases blood glucose by stimulating the re-
lease of glucagon from the alpha cells of the 
pancreas. ll Glucagon acts in opposition to 
insulin by stimulating gluconeogenesis and 
glycogenolysis, thereby increasing blood glu-
cose levelsY These homeostatic mecha-
nisms, however, are unable to compete with 
the increased insulin levels and hypoglyce-
mia ensues.l2 An understanding of the com-
plex hormonal interactions in glucose ho-
meostasis is important in elucidating the 
clinical signs, clinical pathology data, and 
management of canine insulinoma. 
The dog in this case presented with in-
termittent signs characteristic of 
insulinomas. The behavior changes and 
lethargy were due to the neuroglycopenic 
effects of low glucose on the brain.4 The 
muscle tremors and shaking were more re-
lated to the increased sympathetic tone in 
the nervous system.4 Other evidence of in-
creased sympathetic tone such as mydria-
sis, tachycardia, and hunger were not 
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present in this case.l,6,l3 Other clinical signs 
of insulinomas not present in this case are 
blindness, head tilt, diarrhea, syncope, and 
exercise intolerance.l,6,s,12 The dog did have 
polyuria and polydipsia which are also find-
ings in insulinomas.1,5 
A presumptive diagnosis of insulinoma 
can be made by demonstrating 
hyperinsulinemia with concurrent hypogly-
cemia and associated clinical signs.14 Hy-
poglycemia alone does not indicate an 
insulinoma, however, as other conditions 
such as adrenocortical insufficiency, 
endotoxemia, hypopituitarism, starvation, 
pregnancy, exercise, and exogenous insulin 
administration can cause hypoglycemia.B,l2 
But unlike insulinomas, these causes rarely 
result in a blood glucose reading ofless than 
40 mg/dL.B Whipple's triad, which consists 
of subnormal blood glucose concentration, 
clinical signs of hypoglycemia, and resolu-
tion of signs following glucose administra-
tion, is also used to tentatively diagnose 
insulinomas.4,12,15 
The use of insulin to glucose ratios (lGR) 
and the amended insulin to glucose ratio 
(AIGR) in diagnosing insulinomas has been 
subject to considerable controversy. One 
study found that an insulin to glucose ra-
tion of 13.5 was necessary to increase the 
specificity of the ratio in diagnosing an 
insulinoma. This ratio, however, lacked sen-
sitivity in many dogs. The solution was em-
ploying a fasting test in which four blood 
assays for glucose and insulin are done over 
a period of one day. The procedure was found 
to be safe and successful in increasing the 
IGR ratio sensitivity.lB Other authors have 
found the use of an intravenous glucose tol-
erance test to be useful in diagnosis.l 7 The 
use of this test in clinical cases, however, is 
limited due to the time involved in perform-
ing the testP The amended insulin to glu-
cose ratio (AIGR) is another diagnostic tool. 
This ratio, however, has been scrutinized for 
being mathematically equivalent to the IGR 
as well as being too sensitive.2 The dog in 
this case had an IGR value of 53.4 and an 
AIGR value of133.5. These values are con-
siderably greater than the cutoff values of 
13.5 and 30, respectively.B,16 The presump-
tive diagnosis of insulin om a in this case was 
supported by using both the IGR and the 
AIGR. 
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Abdominal radiographs and ultrasound 
are also indicated in suspected cases of 
insulinoma. Abdominal radiographs may aid 
in detecting pancreatic neoplasia and 
hepatomegaly from metastasis, however, 
most insulinomas are not detectable on ra-
diographs.1s Ultrasound, on the other hand, 
allows better visualization of the pancreas. 
Insulinomas often appear as round or lobu-
lar hypo echoic masses.1S In this case, only a 
hyperechoic area in the right lobe of the pan-
creas was detected. This region was not neo-
plastic but was an effect created by a cecal 
adhesion to the pancreas. Ultrasound can 
be especially helpful in localizing a neoplas-
tic area. lS Ultrasound is of considerable 
value during surgery since insulinomas can 
be small and may only be detected through 
palpation. 
Another procedure which shows poten-
tial for clinical use involves staining 
insulinoma cells with new methylene blue 
prior to surgery. One study found this stain 
to be preferentially picked up by insulinoma 
cells in the pancreas as well as in metastatic 
sites such as lymph nodes and the liver.19 
The precise localization of tumor cells us-
ing this technique makes it an appealing 
adjunct in surgical treatment. The stain, 
however, does have adverse effects as it can 
cause pseudo cyanosis and hemolytic ane-
mia.20 
In this case, partial pancreatectomy was 
performed under general anesthesia. Induc-
tion was accomplished with thiopental and 
anesthesia was maintained with isoflurane. 
Thiobarbiturates and inhalation agents are 
the preferred anesthetic agents due to their 
effect of decreasing cerebral glucose metabo-
lism.21 Intravenous dextrose was adminis-
tered to prevent hypoglycemia. 
Partial pancreatectomy was performed 
on the left lobe of the pancreas and a pea-
sized tumor was removed. The method of 
partial pancreatectomy employed was the 
suture fracture technique in which the pan-
creas is ligated and then excised.4,22 Another 
potential method is the dissection and liga-
tion technique in which ductules and blood 
vessels are isolated and ligated prior to ex-
cision.4,22 Both procedures have been dem-
onstrated to be equally effective in prevent-
ing clinical signs due to pancreatitis in the 
postoperative period.22 Approximately 30%-
64 
40% of the pancreas was removed during 
surgery. Although this seems abundant, up 
to 80%-90% of the pancreas can be removed 
without inducing defective fat and carbohy-
drate metabolism.23 Iatrogenic exocrine pan-
creatic insufficiency was not a concern in 
this case. 
Medical management is an alternative 
to surgical removal of insulinomas. Fre-
quent feedings of small, high protein, low 
carbohydrate meals and reducing exercise 
may help to prevent hypoglycemia.1,4,9,13 
Drug therapy can also be instituted. 
Diazoxide is a benzothiadiazine with anti-
insulin effects.9,13 Diazoxide inhibits insulin 
secretion by blocking calcium entry into beta 
cells and raises blood glucose by stimulat-
ing glycogenolysis and gluconeogen-
esis.1,4,12,13 The side effects, however, are 
numerous and include hyperglycemia, dia-
betes mellitus, bone marrow suppression, 
and gastrointestinal disturbances.l,13 Pred-
nisone can also be used for its gluconeogenic 
effects on the liver to combat hypoglyce-
mia.4,12,13 It also acts to decrease the sensi-
tivity of insulin receptors.4 A somatostatin 
analogue, Octreotide, has been used with 
equivocal results. Octreotide decreases in-
sulin secretion after a meal in healthy dogs 
but has variable effects in dogs with 
insulinoma.24 The ineffectiveness of the drug 
in only some animals is believed to be due 
to the lack of somatostatin analogue recep-
tors on the tumor cells.1,24 Other drugs with 
potential use are chemotherapeutic drugs 
such as Streptozotocin and Alloxan, which 
are cytotoxic to beta cells.4,12,13 The nephro-
toxicity of these drugs is severe and poten-
tially irreversible which confines their use 
to only severe refractory cases. 4,12,13 
Doxorubricin and other chemotherapeutics 
are being evaluated in human cases and 
have shown variable results.4,12 Athough 
partial pancreatectomy is the treatment of 
choice, medical management ofinsulinomas 
can be used when surgery is not an option, 
if surgery fails to remove all the neoplastic 
cells, or if the tumor recurs. 
The definitive diagnosis of insulinoma 
in this case was accomplished by histopa-
thology of the pancreas and mesenteric 
lymph node. Most insulinomas occur in ei-
ther the right or left lobe of the pancreas 
although they can occur in the body.l,15 Fur-
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Table S: Canine Insu1inoma Stagingl3 
in 3-5 days.15,25 
Pancreatitis, one of the most 
Stage I - Tumor cells only in the pancreas 
common post-operative complica-
Stage II - Tumor cells in the pancreas and regional 
lymph nodes 
tions, was not observed in the im-
mediate postoperative pe-
riod.4,12,15,21,23,25 This is likely due to 
Stage III - Tumor cells in distant metastatic sites good surgical technique as well as 
thermore, most insulinomas are solitary 
tumors. I Insulinomas are staged according 
to their location and the presence of me-
tastasis (Table 3).13 This dog had stage II 
insulinoma as the tumor cells were present 
in the pancreas and the regional lymph 
nodes. Metastasis to distant organs as oc-
curs in stage III insulinoma was not evi-
denced in this case.13 
The prognosis of the dog in this case is 
guarded as metastasis to regional lymph 
nodes was present. Stage II insulinomas 
have a similar survival time as stage I but 
longer than stage III where distant metasta-
sis is present.I,IO,13 Young dogs have a shorter 
survival time than old dogS.1,IO,13,25 The dog 
in this case carried a better prognosis than 
if it were a younger dog or if distant me-
tastasis had occurred. The malignant nature 
of the tumor, however, is such that regrowth 
is virtually inevitable with an average sur-
vival time of 10-14 months.1,IO,14,15,25 
The dog in this case recovered well from 
surgery. One complication of the surgery is 
hypoglycemia due to incomplete tumor re-
mova1.4,12 In this case, the dog's glucose level 
returned toward normal in the recovery pe-
riod indicating that the tumor was success-
fully removed. Four days after surgery, how-
ever, the dog became hyperglycemic and 
symptomatic. This complication was antici-
pated as diabetes mellitus is known to oc-
cur after insulinoma removal. I 2,23 The result-
ing diabetes is believed to be caused by 
atrophy of the normal beta cells secondary 
to feedback inhibition by the high insulin 
levels produced by the tumor.12 The diabetic 
state may persist for days to months or it 
may be permanentY The dog in this case 
was treated with isophane insulin (NPH in-
sulin) and the blood glucose levels were 
brought to within normal limits. No addi-
tional insulin administration was necessary 
to maintain glucose homeostasis. This re-
turn to a normoglycemic state is a common 
finding as most dogs become normoglycemic 
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withholding food for 48 hours to 
quell pancreatic secretions. The patient did 
develop a delayed pancreatitis ten days af-
ter the surgery. The origin of this pancre-
atitis is questionable since pancreatitis sec-
ondary to surgery usually occurs in the first 
few days after surgery.1,15,21 .24 There is a pos-
sibility of the patient having subclinical pan-
creatitis which worsened with the surgery. 
The patient did recover from this bout of 
pancreatitis after appropriate treatment. 
Conclusion 
Recognizing the clinical findings of canine 
insulinoma is necessary in order to imple-
ment therapy in the affected dog. Other dis-
eases can mimic the clinical signs of canine 
insulinoma, and thus, a thorough under-
standing of the disease is required in order 
to correctly diagnose the disease. It is a dif-
ferential diagnosis one must consider when 
presented with clinical signs of 
hypoglycemia .• 
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